US Broker Ratings

Certara, Inc. (CERT) Stock Analysis: Unveiling a 30% Upside Potential with Strong Buy Ratings

Certara, Inc. (NASDAQ: CERT), a stalwart in the healthcare industry, stands out as a noteworthy contender for investors seeking exposure to the health information services sector...

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating a Complex Landscape with Strategic Growth Prospects

Twist Bioscience Corporation (NASDAQ: TWST) operates at the cutting edge of synthetic DNA manufacturing, a sector with promising applications across multiple industries. From therapeutics and diagnostics..

Perrigo Company plc (PRGO): Investor Outlook – Analyzing a 39.72% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, has been making waves with a potential upside of 39.72% based on current analyst..

Envista Holdings Corporation (NVST): Investor Outlook Amid 11.5% Revenue Growth and Strategic Positioning in Dental Products

Envista Holdings Corporation (NYSE: NVST) stands at the forefront of the healthcare sector, carving a niche in the medical instruments and supplies industry with its extensive..

Galapagos NV (GLPG) Stock Analysis: Understanding the Biotechnology Stock’s Potential Amid Revenue Growth and Analyst Ratings

Investors with an eye on the biotechnology sector may find Galapagos NV (NASDAQ: GLPG) an intriguing company to consider. While the company’s share price recently closed..

Kiniksa Pharmaceuticals, Ltd. (KNSA)

⚠️ No article content returned.

..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

QuidelOrtho Corporation (QDEL) Stock Analysis: Evaluating a 13.45% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to diagnostic testing..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unraveling a 60% Upside Potential

Surgery Partners, Inc. (SGRY), a key player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling investment opportunity with a potential..

Belite Bio, Inc (BLTE) Stock Analysis: A Clinical Stage Biotech with a 19.45% Upside Potential

Belite Bio, Inc (BLTE), a promising player in the biotechnology sector, is drawing attention with its ambitious drug development pipeline and favorable analyst ratings. As the..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech with 9.76% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline of innovative treatments focused on serious..

NovoCure Limited (NVCR): Investor Outlook on a 76% Potential Upside in Medical Device Innovation

NovoCure Limited (NASDAQ: NVCR), a notable player in the healthcare sector, is carving a niche in the medical devices industry with its innovative tumor treating fields..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Marvel with 53% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT), an intriguing player in the biotechnology sector, is capturing investor attention with its promising portfolio of monoclonal antibodies targeting autoimmune diseases. With..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: Analyzing a Promising 50.92% Potential Upside

Crinetics Pharmaceuticals, Inc. (CRNX), a pivotal player in the biotechnology sector, is drawing significant attention from investors with its robust pipeline targeting rare endocrine diseases. The..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Potential 74% Upside as Revenue Surges

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) has become a focal point for investors in the biotechnology sector, not just because of its innovative approach to meeting unmet..

ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring a 95.65% Potential Upside in the Biotechnology Sector

In the ever-evolving landscape of biotechnology, ImmunityBio, Inc. (NASDAQ: IBRX) stands as a noteworthy player with significant growth potential. With a market capitalization of $5.44 billion,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Alignment Healthcare, Inc. (NASDAQ: ALHC) is carving a niche in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. With a..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: A Biotech Stock with 175% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is garnering significant attention in the biotech sector, primarily due to its promising drug pipeline and an impressive potential upside of..

Privia Health Group, Inc. (PRVA) Investor Outlook: Revenue Growth Sparks a 34% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is garnering attention as a noteworthy player in the healthcare sector, specifically in the health information services industry. With a..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating the Challenges with an Attractive 5.24% Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, is facing a complex landscape marked by both challenges and opportunities. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds